Zhou, X.-D.; Chen, Q.-F.; Lin, F.; Wang, L.; Chen, Y.; Liang, D.; Huang, W.; Xiao, F.
Reduced- or Half-Dose Rivaroxaban Following Left Atrial Appendage Closure: A Feasible Antithrombotic Therapy in Patients at High Risk of Bleeding? J. Clin. Med. 2023, 12, 847.
https://doi.org/10.3390/jcm12030847
AMA Style
Zhou X-D, Chen Q-F, Lin F, Wang L, Chen Y, Liang D, Huang W, Xiao F.
Reduced- or Half-Dose Rivaroxaban Following Left Atrial Appendage Closure: A Feasible Antithrombotic Therapy in Patients at High Risk of Bleeding? Journal of Clinical Medicine. 2023; 12(3):847.
https://doi.org/10.3390/jcm12030847
Chicago/Turabian Style
Zhou, Xiao-Dong, Qin-Fen Chen, Fang Lin, Liangguo Wang, Yihe Chen, Dongjie Liang, Weijian Huang, and Fangyi Xiao.
2023. "Reduced- or Half-Dose Rivaroxaban Following Left Atrial Appendage Closure: A Feasible Antithrombotic Therapy in Patients at High Risk of Bleeding?" Journal of Clinical Medicine 12, no. 3: 847.
https://doi.org/10.3390/jcm12030847
APA Style
Zhou, X.-D., Chen, Q.-F., Lin, F., Wang, L., Chen, Y., Liang, D., Huang, W., & Xiao, F.
(2023). Reduced- or Half-Dose Rivaroxaban Following Left Atrial Appendage Closure: A Feasible Antithrombotic Therapy in Patients at High Risk of Bleeding? Journal of Clinical Medicine, 12(3), 847.
https://doi.org/10.3390/jcm12030847
